In the area of cellular biology, single-cell analysis means the study of separate cells isolated from tissues in multi-cellular organisms. The emerging applications of single cell analysis are in various fields such as drug discovery and development, particularly in oncology field, cancer immunotherapy, neurology and stem cells. The global single cell analysis market is estimated to have the CAGR of 18.5% during the forecast period 2016-2023. The rising demand of bio technology industry has become one of the key trends for the single-cell analysis market. Increasing technological advancements in single-cell analysis products, rising biotechnology and biopharmaceutical industries, increasing prevalence of infectious diseases across the globe are the major factors driving the global single cell analysis market. The unwillingness among researchers to accept advanced single-cell analysis products, high cost of instruments, issue related with intellectual property rights limit innovations in assay kits and stringent regulatory approval process may hamper the growth of global single cell analysis market.
Increasing technological advancements in single-cell analysis products, rising biotechnology and biopharmaceutical industries, increasing prevalence of infectious diseases across the globe are the major driving forces of the global single cell analysis market. The growing aging population in the world is major force that is creating huge growth opportunity in the global single cell analysis market. The global rise in chronic diseases, rising applications of single-cell analysis in cancer research and increased funding by government and private firms in research and development and increasing acceptance of stem cell technology is also driving the growth in global single cell analysis market. the growing aging population is one of the major driving factor which is injecting huge growth in global single cell analysis market. The world is currently on the edge of accomplishing a demographic milestone. Since the beginning of history being recorded, young children previously were ahead of the number of people aged 65 or more will go down in the coming future. This change is driven by falling fertility rates and remarkable rise in life expectancy, population aging is expected to continue, even accelerate in the next 10 years. The number of people aged 65 or older are anticipated to grow from an estimated $524 million in year 2010 to nearly 1.5% billion in year 2050, with most of the increase in developing countries. According to WHO the world aged population by the end of 2050 is expected to reach $2 billion that is $900 million in 2015. The remarkable improvements in life expectancy over the past century were part of a shift in the leading causes of disease and death. The rising prevalence of chronic life style oriented diseases is also increasing the growth in the global single cell analysis market. Cancer is the major disease which is increasing with a huge pace, according to WHO, by the end of 2020 there will be around $15 million people who are projected to suffer from cancer which increases by around 50%.
The global single cell analysis market has huge opportunities such as high growth opportunity in the emerging countries, growth potential in single-cell sequencing (SCS), fostering stem cell research, integration of micro fluidics in single-cell analysis and growing potential in emerging economies is expected to contribute a lot in the growth of global single cell analysis market.
Source: OBRC Analysis.
The report on global single cell analysis market includes cell type, end-user, application, technique and by product.
Product is segmented into:
- Consumables
- Instruments
Cell segment of single cell analysis includes:
- Human Cells
- Animal Cells
- Microbial Cells
Technique segment of single cell analysis includes:
- Flow Cytometry
- Next-Generation Sequencing
- Polymerase Chain Reaction
- Microscopy
- Mass Spectrometry
- Other Techniques
Application segment of single cell analysis includes:
- Research Applications
- Medical Applications
End-user segment of single cell analysis include:
- Academic & Research Laboratories
- Biotechnology and Pharmaceutical Companies
- Hospitals and Diagnostic Laboratories
- Cell Banks and IVF Centers
The revenue for the above application and end-user segments are specific to the single cell analysis market. However, the total revenue of these application and end-user in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up cell type and product segment.
The global single cell analysis market report has been geographically segmented in:
- North America (U.S. & Canada)
- Asia Pacific (China, India, Japan, RoAPAC)
- Europe (UK, France, Germany, RoE)
- Rest of World
The single cell analysis is segmented on the basis of application, cell type, product, end user, technique and geography. The application segment is segmented into research application and medical application. The medical application is further segmented into circulating tumour cells (CTCS), in vitro fertilization and non-invasive prenatal diagnosis. The research application is also sub segmented into cancer, immunology, neurology, stem cells and other applications. The end user segment is also segmented into biotechnology and biopharmaceutical companies, cell banks and IVF centres, hospitals and diagnostic laboratories and research & academic laboratories. The cell type segment is segmented into animal cells, human cells and microbial cells. The techniques segment is segmented into flow cytometry, mass spectrometry, microscopy, next-generation sequencing (NGS), PCR (Polymerase Chain Reaction) and other techniques. The product segment is further segmented into consumables and instruments.
The global single cell analysis market is driven by the presence of some the prominent player in the market. Becton, Dickinson and Company, Bioheart, Corning, Inc., Medtronic’s PLC, Celgene Corporation, GE Healthcare, illumine Inc., Merck KGAA, Stem cell Technologies, Stryker Corporation, Thermo Fisher Scientific, Inc
On the basis of geography North America, Europe, Asia Pacific and RoW are the major segments. North America dominates the single cell analysis market; the domination is due to presence of some key player of single cell analysis who invests a huge amount for the development of new technology in the single cell analysis which is increasing the North America share in the global single cell analysis market. The growth of north America is driven by number of factors such as growing aging population in the region, rising funding from private and government for new technological advancement in stem cell technology and tissue engineering. The rising demonstration of stem cell therapy for the treatment is also driving the growth in the North American single cell analysis market. Asia pacific market is expected to grow with a high CAGR in forecast period. The demand in the Asia Pacific is majorly driven by rising demand for stem cell therapies for the treatment due to increasing number of patient population in the region and increasing prevalence of chronic lifestyle diseases.
The major market players of the global single cell analysis market are:
- AGILENT TECHNOLOGIES INC
- GE HEALTHCARE
- STRYKER CORPORATION
- THERMO FISHER SCIENTIFIC, INC.
- QIAGEN N.V.
- OTHERS
These companies use various strategies such as merger & acquisition, collaboration, partnership and product launch. Whereas, merger & acquisition is the key strategy adopted by the companies in the single cell analysis market.
For Example. In 2015, the Medtronic announced the acquisition of Covidien plc. which was an Irish-headquartered global health care products company and manufacturer and supplier of medical devices. This acquisition helped Medtronic to enhance the effectiveness if their healthcare product range and also assist the firm to expand their geographical presence.
The report covers detailed analysis of companies which comprises of overview, SCOT analysis, product portfolio, strategic initiative, strategic analysis, competitive landscape and market share analysis in single cell analysis market.
Key reasons to buy the report:
- The report includes market estimation, forecast and analysis for 2016-2023
- Report includes detailed analysis of different segments such as application, end-user and product of global single cell analysis.
- Identify and understand the strengths, opportunities, challenges and threat of the global single cell analysis market.
- Covers details analysis of Porters 5 force model and other strategic models and also covers revenues, market share analysis, and competitive landscape analysis of major players of global single cell analysis market.
- Detailed analysis of various regulatory policies which affect the global single cell analysis market.
How we are different from others:
At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global single cell analysismarket offers detailed analysis of strategic models such as investment vs. adoption model, see saw analysis and others strategic models. Also, the report contains the detailed analysis of application, adoption scenario and decision support for each segment. The report discusses competitive landscape of the single cell analysis market, with giving extensive SCOT analysis of key companies.
Key findings of the global single cell analysis market:
- North America held highest revenue share in 2016.
- Flow cytometry is expected to dominate the market.
- Consumables of product segment is expected to dominate the market.
- Acquisition is the key strategy adopted by players of global single cell analysis market.
